The discovery of α1-antitrypsin and its role in health and disease

Respiratory Medicine

Volumn 105, Issue 8, 2011, Pages 1129-1139

  Janciauskiene, Sabina M ^a   Bals, Robert ^b   Koczulla, Rembert ^c   Vogelmeier, Claus ^c   Köhnlein, Thomas ^a   Welte, Tobias ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

1 Antitrypsin; Augmentation therapy; Chronic obstructive pulmonary disease; Deficiency; Inflammation

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIINFLAMMATORY ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; EMPHYSEMA; HUMAN; LIVER DISEASE; LUNG DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA;

EID: 79959237123     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.02.002     Document Type: Review

References (140)

1. Fermi C, Pernossi L. Untersuchungen uber die enzyme, Vergleichende Studie. Z Hyg Infektionskr 1894;18:83-9.
2. Schultze HE, Goilner I, Heide K, Schoenenberger M, Schwick G. Zur Kenntnis der alpha-globulin des menschlichen nirmal serums. Naturforsch 1955;10:463.
3. Carrell R, Travis J. α1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci 1985;10:20-4.
4. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001;276:33293-6.
5. Perlmutter DH, Kay RM, Cole FS, Rossing TH, Van Thiel D, et al. The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A 1985;82:6918-21. (Pubitemid 16209665)
6. Ray MB, Geboes K, Callea F, Desmet VJ. Alpha-1-antitrypsin immunoreactivity in gastric carcinoid. Histopathology 1982;6:289-97. (Pubitemid 12123135)
7. Geboes K, Ray MB, Rutgeerts P, Callea F, Desmet VJ, et al. Morphological identification of alpha-I-antitrypsin in the human small intestine. Histopathology 1982;6:55-60. (Pubitemid 12164787)
8. Bosković G, Twining SS. Local control of alpha1-proteinase inhibitor levels: regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines. Biochim Biophys Acta 1998;27:37-46. (Pubitemid 28288280)
9. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R. An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis. Br J Cancer 1992;65:300-2.
10. Kalsheker N, Morley S, Morgan K. Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 2002;30:93-8.
11. Chowanadisai W, Lönnerdal B. Alpha(1)-antitrypsin and antichymotrypsin in human milk: origin, concentrations, and stability. Am J Clin Nutr 2002;76:828-33.
12. Berman MB, Barber JC, Talamo RC, Langley CE. Corneal ulceration and the serum antiproteases. I. Alpha 1-antitrypsin. Invest Ophthalmol 1973;12:759-70.
13. Eden E. Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis. COPD 2010;7:366-74.
14. Huang C. Comparative proteomic analysis of human whole saliva. Arch Oral Biol 2004;49:951-62. (Pubitemid 39366832)
15. Janciauskiene S, Toth E, Sahlin S, Eriksson S. Immunochemical and functional properties of biliary alpha-1-antitrypsin. Scand J Clin Lab Invest 1996;56:597-608. (Pubitemid 26423585)
16. Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta 2001;1535:221-35. (Pubitemid 32241132)
17. Boskovic G, Twining SS. Retinol and retinaldehyde specifically increase alpha1-proteinase inhibitor in the human cornea. Biochem J 1997;322:751-6. (Pubitemid 27135620)
18. Perlmutter DH, Punsal PI. Distinct and additive effects of elastase and endotoxin on expression of alpha 1 proteinase inhibitor in mononuclear phagocytes. J Biol Chem1988;263:16499-503.
19. Knoell DL, Ralston DR, Coulter KR, Wewers MD. Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am J Respir Crit Care Med 1998;157:246-55. (Pubitemid 28071289)
20. Bosco D, Meda P, Morel P, Matthey-Doret D, Caille D, et al. Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells. Diabetologia 2005;48:1523-33. (Pubitemid 41175505)
21. Faust D, Hormann S, Friedrich-Sander M, Milovic V, Stein J. Butyrate and the cytokine-induced alpha1-proteinase inhibitor release in intestinal epithelial cells. Eur J Clin Invest 2001;31:1060-3.
22. Perlmutter DH, Travis J, Punsal PI. Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency. J Clin Invest 1988;81:1774-80.
23. Gooptu B, Lomas DA. Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu Rev Biochem 2009;78:147-76.
24. Luo LY, Jiang W. Inhibition profiles of human tissue kallikreins by serine protease inhibitors. Biol Chem 2006;387:813-6. (Pubitemid 43964806)
25. Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, et al. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am J Physiol Cell Physiol 2008;295:C423-31.
26. Janciauskiene S, Nita I, Subramaniyam D, Li Q, Lancaster Jr JR, et al. Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro. Am J Respir Cell Mol Biol 2008;39:631-7.
27. Lazrak A, Nita I, Subramaniyam D, Wei S, Song W, et al. Alpha(1)-antitrypsin inhibits epithelial Na+ transport in vitro and in vivo. Am J Respir Cell Mol Biol 2009;41:261-70.
28. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, et al. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006;169:1155-66. (Pubitemid 351194353)
29. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, et al. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 2007;56:1316-23.
30. Bergin DA, Reeves EP, Meleady P, Henry M, McElvaney OJ, et al. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest 2010;120:4236-50.
31. Arora PK, Miller HC, Aronson LD. Alpha1-antitrypsin is an effector of immunological stasis. Nature 1978;274:589-90.
32. Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, et al. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 2001;186:73-81.
33. Bucurenci N, Blake DR, Chidwick K, Winyard PG. Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett 1992;300:21-4.
34. She QB, Mukherjee JJ, Crilly KS, Kiss Z. Alpha(1)-antitrypsin can increase insulin-induced mitogenesis in various fibroblast and epithelial cell lines. FEBS Lett 2000;473:33-6.
35. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993;178:1629-36. (Pubitemid 23318441)
36. Libert C, Van MW, Brouckaert P, Fiers W. Alpha1-antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996;157:5126-9. (Pubitemid 126449595)
37. Churg A, Dai J, Zay K, Karsan A, Hendricks R, et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001;81:1119-31. (Pubitemid 32772072)
38. Graziadei I, Weiss G, Bohm A, Werner-Felmayer G, Vogel W. Unidirectional upregulation of the synthesis of the major iron proteins, transferrin-receptor and ferritin, in HepG2 cells by the acute-phase protein alpha1-antitrypsin. J Hepatol 1997;27:716-25. (Pubitemid 27448756)
39. Knappstein S, Ide T, Schmidt MA, Heusipp G. Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains. Infect Immun 2004;72:4344-50. (Pubitemid 38989289)
40. Forney JR, Yang S, Healey MC. Interaction of the human serine protease inhibitor alpha-1-antitrypsin with cryptosporidium parvum. J Parasitol 1996;82:496-502. (Pubitemid 26172553)
41. Griese M, Latzin P, Kappler M, Weckerle K, Heinzlmaier T, et al. Alpha1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. J Eur Respir 2007;29:240-50. (Pubitemid 46231900)
42. Münch J, Ständker L, Adermann K, Schulz A, Schindler M, et al. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 2007;129:263-75. (Pubitemid 46574967)
43. Forssmann WG, The YH, Stoll M, Adermann K, Albrecht U, et al. Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide. Sci Transl Med 2010;2:63. re3.
44. Janciauskiene SM, Nita IM, Stevens T. Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 2007;282:8573-82. (Pubitemid 47093518)
45. Subramaniyam D, Virtala R, Pawlowski K, Clausen IG, Warkentin S, et al. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int J Biochem Cell Biol 2008;40:258-71. (Pubitemid 350137878)
46. Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, et al. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 2008;105:16242-7.
47. Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL, et al. Alpha1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A 2008;105:16236-41.
48. Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM. α 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells. Islets 2010;2:185-9.
49. Laurell CB, Thulin E. Complexes in plasma between light chain kappa immunoglobulins and alpha 1-antitrypsin respectively prealbumin. Immunochemistry 1974;11:703-9.
50. Austin GE, Mullins RH, Morin LG. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. Clin Chem 1987;33:2220-4.
51. Finotti P, Pagetta A. A heat shock protein70 fusion protein with alpha1-antitrypsin in plasma of type 1 diabetic subjects. Biochem Biophys Res Commun 2004;315:297-305. (Pubitemid 38183107)
52. Scott LJ, Evans EL, Dawes PT, Russell GI, Mattey DL. Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se. Br J Rheumatol 1998;37:398-404.
53. Zhang WM, Finne P, Leinonen J, Stenman UH. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases. Scand J Clin Lab Invest Suppl 2000;233:51-8. (Pubitemid 32147173)
54. Donners MM, Verluyten MJ, Bouwman FG, Mariman EC, Devreese B, et al. Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol 2005;206:39-45. (Pubitemid 40613432)
55. Eriksson S. A 30-year perspective on alpha 1-antitrypsin deficiency. Chest 1996;110:237S-42S.
56. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204:345-51. (Pubitemid 9051719)
57. Sharp HL, Bridges RA, Krivit W, Freier EF. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969;73:934-9.
58. Lomas DA. Loop-sheet polymerization: the structural basis of Z alpha 1-antitrypsin accumulation in the liver. Clin Sci (Lond) 1994;86:489-95. (Pubitemid 24181935)
59. Owen MC, Carrell RW, Brennan SO. The abnormality of the S variant of human alpha-1-antitrypsin. Biochim Biophys Acta 1976;453:257-61.
60. Jeppsson J. Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ. FEBS Lett 1976;65:195-7.
61. Carrell RW, Lomas DA. Alpha1-antitrypsin deficiency - a model for conformational diseases. N Engl J Med 2002;346:45-53. (Pubitemid 34438920)
62. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994;269:15957-60. (Pubitemid 24209273)
63. Blanco I, de Serres FJ, Fernandez-Bustillo E, Lara B, Miravitlles M. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J 2006;27:77-84. (Pubitemid 43092670)
64. Sveger T. Liver disease in lapha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21.
65. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002;136:270-9. (Pubitemid 34150756)
66. Ferrarotti I, Baccheschi J, Zorzetto M, Tinelli C, Corda L, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet 2005;42:282-7. (Pubitemid 40380312)
67. Martin JP, Sesboue R, Charlionet R, Ropartz C, Pereira MT. Genetic variants of serum alpha1-antitrypsin (Pi types) in Portuguese. Hum Hered 1976;26:310-4.
68. Seyama K, Nukiwa T, Takabe K, Takahashi H, Miyake K, et al. Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem 1991;266:12627-32. (Pubitemid 21907141)
69. Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 2004;59:164-9.
70. Seixas S, Garcia O, Trovoada MJ, Santos MT, Amorim A, et al. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum Genet 2001;108:20-30. (Pubitemid 32140538)
71. Fagerhol MK, Hauge HE. The Pi phenotype MP. Discovery of a ninth allele belonging to the system of inherited variants of serum alpha 1 antitrypsin. Vox Sang 1968;15:396-400.
72. Ranes J, Stoller JK. A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med 2005;26:154-66. (Pubitemid 40617294)
73. Wittes J, Wu MC. Natural history of alpha-1 antitrypsin deficiency. In: Crystal RG, editor. Alpha-1 antitrypsin deficiency. New York: Marcel Dekker; 1996. p. 281-91.
74. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
75. Bals R, Koczulla R, Kotke V, Andress J, Blackert K, et al. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med 2007;101:1708-14. (Pubitemid 46947877)
76. Sitkauskiene B, Serapinas D, Blanco I, Fernández-Bustillo E, Janciauskiene S, et al. Screening for alpha1-antitrypsin deficiency in lithuanian patients with COPD. Respir Med 2008;102:1654-8.
77. Colp C, Pappas J, Moran D, Lieberman J. Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest 1993;103:812-5. (Pubitemid 23086180)
78. Dowson LJ, Guest PJ, Stockley RA. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 2001;164:1805-9.
79. Alam S, Li Z, Janciauskiene S, Mahadeva R. Oxidation of Z {alpha}1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. Am J Respir Cell Mol Biol; 2010 [Epub ahead of print].
80. Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 2010;329:229-32.
81. Fairbanks KD, Tavill AS. Liver disease in alpha 1-antitrypsin deficiency: a review. Am J Gastroenterol 2008;103:2136-41.
82. Perlmutter DH, Brodsky JL, Balistreri WF, Trapnell BC. Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review. Hepatology 2007;45:1313-23. (Pubitemid 46775796)
83. Avezov E, Frenkel Z, Ehrlich M, Herscovics A, Lederkremer GZ. Endoplasmic reticulum (ER) mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ER-associated degradation. Mol Biol Cell 2008;19:216-25. (Pubitemid 351186147)
84. Pan S, Huang L, McPherson J, Muzny D, Rouhani F, et al. Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1antitrypsindeficiency. Hepatology 2009;50:275-81.
85. Primhak RA, Tanner MS. Alpha-1 antitrypsin deficiency. Arch Dis Child 2001;85:2-5.
86. Francavilla R, Castellaneta SP, Hadzic N, Chambers SM, Portmann B, et al. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol 2000;32:986-92. (Pubitemid 30368092)
87. Fleming LE, Oquendo S, Bean JA, Tamer R, Finn S, et al. Pilot detection study of alpha(1) antitrypsin deficiency in a targeted population. Am J Med Genet 2001;103:69-74.
88. Kalsheker NA. Alpha1-antitrypsin deficiency: best clinical practice. J Clin Pathol 2009;62:865-9.
89. Ellis G, Goldberg DM, Spooner RJ, Ward AM. Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 1978;70:248-58. (Pubitemid 9005446)
90. Stoller JK, Fromer L, Brantly M, Stocks J, Strange C. Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. Cleve Clin J Med 2007;74:869-74.
91. Hendrick SJ, Silverman AK, Solomon AR, Headington JT. Alpha 1-antitrypsin deficiency associated with panniculitis. J Am Acad Dermatol 1988;(4 Pt 1):684-92.
92. Requena L, Sánchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001;45:325-61 [quiz 62-4].
93. Smith KC, Su WP, Pittelkow MR, Winkelmann RK. Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of alpha 1-antitrypsin. J Am Acad Dermatol 1989;21:1192-6. (Pubitemid 20216987)
94. Gross B, Grebe M, Wencker M, Stoller JK, Bjursten LM, et al. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology 2009;218:370-5.
95. O'Riordan K, Blei AT, Rao MS, Abecassis MM. Alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha1-antitrypsin administration and liver transplantation. Transplantation 1997;63:480-2. (Pubitemid 27086048)
96. Furey NL, Golden RS, Potts SR. Treatment of alpha-1-antitrypsin deficiency, massive edema, and panniculitis with alpha-1 protease inhibitor. Ann Intern Med 1996;125:699.
97. Esnault VL, Testa A, Audrain M, Rogé C, Hamidou M, et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993;43:1329-32. (Pubitemid 23161420)
98. O'Donoghue DJ, Guickian M, Blundell G, Winney RJ. Alpha-1-proteinase inhibitor and pulmonary haemorrhage in systemic vasculitis. Adv Exp Med Biol 1993;336:331-5. (Pubitemid 24004941)
99. Esnault VL, Audrain MA, Sesboüé R. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis. Exp Clin Immunogenet 1997;14:206-13. (Pubitemid 28041087)
100. Teh LG, Steven MM, Capell HA. Alpha-1-antitrypsin associated liver disease in rheumatoid arthritis. Postgrad Med J 1985;61:171-2. (Pubitemid 15106487)
101. Cox DW. Transmission of Z allele from heterozygotes for alpha1-antitrypsin deficiency. Am J Hum Genet 1980;32:455-7.
102. Beckman G, Beckman L, Bjelle A, Dahlqvist SR. Alpha-1-antitrypsin types and rheumatoid arthritis. Clin Genet 1984;25:496-9. (Pubitemid 14104902)
103. Davis ID, Burke B, Freese D, Sharp HL, Kim Y. The pathologic spectrum of the nephropathy associated with alpha 1-antitrypsin deficiency. Hum Pathol 1992;23:57-62.
104. Noble-Jamieson G, Thiru S, Johnston P, Friend P, Barnes ND. Glomerulonephritis with end-stage liver disease in childhood. Lancet 1992;339:706-7.
105. Sandström CS, Ohlsson B, Melander O, Westin U, Mahadeva R, et al. An association between type 2 diabetes and alpha-antitrypsin deficiency. Diabet Med 2008;25:1370-3.
106. Valverde R, Rosales B, Ortiz-de Frutos FJ, Rodríguez-Peralto JL, Ortiz-Romero PL. Alpha-1-antitrypsin deficiency panniculitis. Dermatol Clin 2008;26:447-51.
107. Lyon MJ. Metabolic panniculitis: alpha-1 antitrypsin deficiency panniculitis and pancreatic panniculitis. Dermatol Ther 2010;23:368-74.
108. Esnault VL. ANCA-positive vasculitis and alpha 1-antitrypsin deficiency: could free ANCA antigens released by neutrophils mediate vasculitic lesions? Nephro Dlial Transplant 1997;12:249-51.
109. Breit SN, Wakefield D, Robinson JP, Luckhurst E, Clark P, et al. The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 1985;35:363-80. (Pubitemid 15033372)
110. Kilty SJ, Desrosiers MY. Chronic sinusitis and alpha1-antitrypsin deficiency: potential role for protease in rhinosinusitis? J Otolaryngol Head Neck Surg 2008;37:E179-82.
111. Maune S, Rath NF, Görögh T, Steinert R. Genetic disposition to chronic polypoid sinusitis and alpha 1-proteinase inhibitor deficiency types. HNO 1995;43:537-9.
112. Fearnley IR, Spalton DJ, Ward AM, Slavin B, Muncey F. Alpha 1-antitrypsin phenotypes in acute anterior uveitis. Br J Ophthalmol 1988;72:636-9.
113. Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: clinical manifestations and natural history. Thorax 2004;59:441-5.
114. Witt H, Kage A, Luck W, Becker M. Alpha1-antitrypsin genotypes in patients with chronic pancreatitis. Scand J Gastroenterol 2002;37:356-9. (Pubitemid 34194824)
115. Rabassa AA, Schwartz MR, Ertan A. Alpha 1-antitrypsin deficiency and chronic pancreatitis. Dig Dis Sci 1995;40:1997-2001.
116. Gambichler T, Reich S, Banasch M, Altmeyer P. Complex extra-intestinal complications of ulcerative colitis in a patient with alpha1-antitrypsin deficiency. Eur J Med Res 2006;11:135-8.
117. Folwaczny C, Urban S, Schröder M, Hofmann B, Noehl N, et al. Alpha1-antitrypsin alleles and phenotypes in patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:78-81. (Pubitemid 28114073)
118. Pons Romero F, Casafont F, Rodriguez de Lope C, San Miguel G, Artiñano E, et al. Could alpha 1 antitrypsin deficiency have any role in the development of celiac sprue after gastric operations? J Clin Gastroenterol 1986;8:559-61.
119. Klasen EC, Polanco I, Biemond I, Vazquez C, Peña AS. Alpha 1-antitrypsin and coeliac disease in Spain. Gut 1980;21:948-50. (Pubitemid 11213468)
120. Elzouki AN, Tóth E, Florén CH, Lindgren S, Fork FT, et al. Alpha1-antitrypsin deficiency may be a risk factor for duodenal ulcer in patients with helicobacter pylori infection. Scand J Gastroenterol 2000;35:32-5. (Pubitemid 30066768)
121. Andre F, Andre C, Lambert R, Descos F. Prevalence of alpha1-antitrypsin deficiency in patients with gastric or duodenal ulcer. Biomedicine 1974;21:222-4.
122. Lisowska-Myjak B, Pachecka J, Kaczyńska B, Miszkurka G, Kadziela K. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol 2006;43:88-92. (Pubitemid 46072201)
123. Callea F, Fevery J, Desmet VJ. Simultaneous alpha-1-antitrypsin accumulation in liver and pancreas. Hum Pathol 1984;15:293-5. (Pubitemid 15162482)
124. Ting SM, Toth T, Caskey F. Alpha1-antitrypsin (A1AT) deficiency presenting with IgA nephropathy and nephrotic syndrome: is renal involvement caused by A1AT deposition? Clin Nephrol 2008;70:159-62.
125. Dieriks B, Hoorens A, Vanden Houte K, Verbeelen D. Alpha-1-antitrypsin deficiency and mesangio-capillary glomerulonephritis in an elderly patient. Nephrol Dial Transplant 2006;21:2027. (Pubitemid 43985747)
126. Szönyi L, Dobos M, Vásárhelyi B, Héninger E, Vas T, et al. Prevalence of alpha1-antitrypsin phenotypes in patients with IgA nephropathy. Clin Nephrol 2004;62:418-22. (Pubitemid 39654579)
127. Ablin JN, Bar-Shira A, Yaron M, Orr-Urtreger A. Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin. Clin Exp Rheumatol 2009;27:S33-8.
128. Blanco I, Béritze N, Argüelles M, Cárcaba V, Fernández F, et al. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumato 2010;29:1403-12.
129. Schelfout K, Tjalma WA, Cooremans ID, Coeman DC, Colpaert CG, et al. Observations of an idiopathic granulomatous mastitis. Eur J Obstet Gynecol Reprod Biol 2001;97:260-2. (Pubitemid 32645669)
130. Frederick WG, Enriquez R, Bookbinder MJ. Peripheral neuropathy associated with alpha 1-antitrypsin deficiency. Arch Neurol 1990;47:233-5. (Pubitemid 20058127)
131. Elzouki AN, Rydén Ahlgren A, Länne T, Sonesson B, Eriksson S. Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? Eur J Vasc Endovasc Surg 1999;17:149-54. (Pubitemid 29081984)
132. Elzouki AN, Eriksson S. Severe alpha 1-antitrypsin deficiency and intracranial aneurysms. Lancet 1994;343:1037. (Pubitemid 24122619)
133. Pezzini A, Magoni M, Corda L, Pini L, Medicina D, et al. Alpha-1-antitrypsin deficiency-associated cervical artery dissection: report of three cases. Eur Neurol 2002;47:201-4. (Pubitemid 34621583)
134. Schardey HM, Hernandez-Richter T, Klueppelberg U, Tutsch-Bauer E, Lauterjung L. Alleles of the alpha-1-antitrypsin phenotype in patients with aortic aneurysms. J Cardiovasc Surg (Torino) 1998;39:535-9. (Pubitemid 28526006)
135. Talmud PJ, Martin S, Steiner G, Flavell DM, Whitehouse DB, et al. Diabetes atherosclerosis intervention study investigators. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler Thromb Vasc Biol 2003;23:644-9.
136. Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008;168:1097-103. (Pubitemid 351749227)
137. Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, et al. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol; 2010 [Epub ahead of print].
138. Topic A, Ljujic M, Nikolic A, Petrovic-Stanojevic N, Dopudja-Pantic V, et al. Alpha-1-antitrypsin phenotypes and neutrophil elastase gene promoter polymorphisms in lung cancer. Pathol Oncol Res; 2010 [Epub ahead of print].
139. Lindor NM, Yang P, Evans I, Schowalter K, De Andrade M, et al. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab 2010;99:157-9.
140. Laurell CB, Eriksson S. The elecrophoreic alpha-1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scan J Clin Lab Invest 1963;15:132-40.